Skip to main content
International Journal of Spine Surgery logoLink to International Journal of Spine Surgery
. 2021 Apr 16;15(2):234–242. doi: 10.14444/8008

Combined Depression and Anxiety Influence Patient-Reported Outcomes after Lumbar Fusion

Dhruv KC Goyal 1,, Justin D Stull 1, Srikanth N Divi 1, Matthew S Galtta 1, Daniel R Bowles 1, Kristen J Nicholson 1, I David Kaye 1, Barrett I Woods 1, Mark F Kurd 1, Kris E Radcliff 1, Jeffrey A Rihn 1, D Greg Anderson 1, Alan S Hilibrand 1, Christopher K Kepler 1, Alexander R Vaccaro 1, Gregory D Schroeder 1
PMCID: PMC8059386  PMID: 33900980

Abstract

Background

Currently, no studies have assessed what effect the presence of both anxiety and depression may have on patient-reported outcome measurements (PROMs) compared to patients with a single or no mental health diagnosis.

Methods

Patients undergoing 1- to 3-level lumbar fusion at a single academic hospital were retrospectively queried. Anyone with depression and/or anxiety was identified using an existing clinical diagnosis in the medical chart. Patients were separated into 3 groups: no depression or anxiety (NDA), depression or anxiety alone (DOA), and combined depression and anxiety (DAA). Absolute PROMs, recovery ratios, and the percentage of patients achieving minimal clinically important difference (% MCID) between groups were compared using univariate and multivariate analysis.

Results

Of the 391 patients included in the cohort, 323 (82.6%) were in the NDA group, 37 (9.5%) in the DOA group, and 31 (7.9%) in the DAA group. Patients in the DAA group had significantly worse outcome scores before and after surgery with respect to Short Form-12 mental component score (MCS-12) and Oswestry Disability Index (ODI) scores (P <.001); however, the change in PROMs, recovery ratio, % MCID were not found to be significantly different between groups. Using multivariate analysis, the DAA group was found to be an independent predictor of worse improvement in MCS-12 and ODI scores (P = .026 and P = .001, respectively).

Conclusions

Patients with combined anxiety and depression fared worse with respect to disability before and after surgery compared to patients with a single diagnosis or no mental health diagnosis; however, there were no significant differences in recovery ratio or % MCID.

Level of Evidence

3.

Clinical Relevance

Combined anxiety and depression may predict less improvement in MCS-12 and ODI after lumbar arthrodesis compared with single or no mental health diagnosis.

Keywords: PROMs, HRQOL outcome scales, SF-12, PCS-12, MCS-12, ODI, VAS back, VAS leg, depression, anxiety, mental health, lumbar, arthrodesis, fusion

INTRODUCTION

Lumbar fusion is a commonly performed surgery to address symptomatic spinal stenosis with concomitant instability. Over the past decade, the rate of lumbar fusions has been steadily increasing, with almost 200 000 surgeries performed annually.1 Elective lumbar fusion for degenerative disease, specifically for spondylolisthesis, has been reported to result in higher patient-satisfaction scores and improved patient-reported outcome measurements (PROMs).26 Many risk factors have been identified that ultimately affect patient outcomes following fusion; however, preoperative mental health comorbidities including anxiety and depression, have been associated with higher rates of complications and worse patient outcomes.710

There is growing interest in PROMs in spine literature; as such, it is important to understand how these metrics may be translated into improved patient care. While PROMs may be used to objectively determine the effectiveness of a surgical intervention, further work must be done to understand how these metrics change in the presence of baseline risk factors. Currently, there is conflicting evidence as to whether preoperative mental health comorbidities lead to worse outcomes following lumbar surgery.1118 Even more poorly defined is how these baseline conditions affect PROMs after surgical intervention for degenerative lumbar disease. Given increasing attention towards outcomes-based care in spine surgery, the purpose of this study was to determine if, and to what extent, patients with a preoperative diagnosis of depression and/or anxiety demonstrate worse outcomes after lumbar fusion.

METHODS

Patient Selection and Data Collection

This study was approved by the Institutional Review Board at the Thomas Jefferson University Hospital. Each author certifies that his or her institution approved the human protocol for this investigation and that all investigations were conducted in conformity with ethical principles of research. After gaining approval from the Institutional Review Board, a retrospective cohort study was initiated on patients who received lumbar fusion surgery from one of several orthopedic spine surgeons at a single high-volume center between January 1, 2013, and December 31, 2017. Patients—including those with spondylolisthesis, scoliosis, recurrent disc herniation, or lumbar spinal stenosis—underwent either posterolateral fusion alone or combined posterolateral fusion with anterior lumbar interbody fusion or transforaminal lumbar interbody fusion to address a variety of degenerative lumbar conditions. Anyone under 18 years of age and those who demonstrated under 1 year of clinical follow-up were excluded from the final cohort; furthermore, individuals who received surgical intervention to address malignancy, infection, trauma, or revision of a prior lumbar surgery were also left out of the final sample.

A standard set of demographic data and surgical characteristics was collected and recorded for each patient from the institution's electronic health record system (eCW V11, eClinicalWorks, Westborough, Massachusetts), including age, sex, body mass index (BMI), smoking status (never, current, former), preoperative diagnosis, total number of levels decompressed, total number of levels fused, months of clinical follow-up, and duration of symptoms prior to surgical intervention (<3 months, 3-6 months, >6 months). Baseline and postoperative (1-year) PROMs—including the Short Form-12 physical component score (PCS-12) and mental component score (MCS-12), the Oswestry Disability Index (ODI), and the Visual Analogue Scale back (VAS back) and leg (VAS leg) pain scores—were obtained through a structured query language search in the institution's PROM tracking software (OBERD, Columbia, MO). Each outcome was measured at baseline and the 1-year postoperative mark.

Electronic health records and office notes were then reviewed to assess whether a mental health diagnosis was present prior to surgery. Subsequently, patients were split into 1 of 3 groups based on the presence of any officially documented diagnosis of depression and/or anxiety in their records: (1) no depression or anxiety (NDA) group; (2) depression or anxiety (DOA) group; and (3) depression and anxiety (DAA) group. In a secondary analysis, patients in the DOA group were split into depression-only (DO) and anxiety-only (AO) groups.

Statistical Analysis

Data were assessed for normality of distribution using measures of skewness and kurtosis, and the Shapiro-Wilk test. Demographics and surgical data were compared between the 3 groups. Each set of PROMs was assessed for changes from baseline to postoperative measurement within groups using paired samples t test. Outcomes were then compared between groups for differences in preoperative, postoperative, and delta (postoperative minus preoperative) scores. Categorical variables were compared using Pearson χ2analysis or Fisher exact test, and continuous variables were compared using 1-way ANOVA or Kruskal-Wallis H test with Bonferroni and Dunn multiple pairwise comparison testing, respectively, for post-hoc analysis. Two additional measures of improvement were calculated and compared between groups: recovery ratios (RR) and the percentage of patients who ended up achieving the minimum clinically important difference (% MCID) at final follow-up. RR was defined as delta score/(optimal score – baseline score), where 100 was used as an optimal score for PCS-12 and MCS-12 and a score of 0 was optimal for ODI, VAS back, and VAS leg.19 The % MCID calculated for each PROM was based on the following threshold values: PCS-12, 8.8 points; MCS-12, 9.3 points; ODI, 6.8 points; VAS back, 2.1 points; and VAS leg, 2.4 points.20,21 Finally, a set of multiple linear regression analyses was performed to determine whether preoperative mental health diagnoses were predictors of worse outcomes after lumbar fusion surgery. Each regression was conducted using the NDA group as a baseline for comparison and controlled for age, sex, BMI, smoking status, preoperative diagnosis, number of levels decompressed, number of levels fused, months of clinical follow-up, and duration of symptoms prior to surgery. Statistical analysis was also repeated by splitting the DOA group into DO and AO groups in the secondary analysis. All statistical analyses were performed using the SPSS version 24 (IBM Corporation, Armonk, NY). A P value less than .05 was considered to be statistically significant.

RESULTS

Patient Demographics

A total 391 patients were included in the final set of analysis, with 323 (82.6%) in the NDA group, 37 (9.5%) in the DOA group, and 31 (7.9%) in the DAA group. The average age of patients in the overall cohort was 62 (95% confidence interval [CI]: 61, 64) years, mean BMI was 30.5 (95% CI: 29.9, 31.1), and total number of male participants was 212 (54.2%). There were 264 never (67.5%), 30 current (7.7%), and 97 former (24.8%) smokers in this set of patients, 272 (69.6%) of which underwent surgical intervention to address spondylolisthesis, 53 (18.2%) for scoliosis, 12 (3.1%) for recurrent nucleus pulposus herniation, and 54 (9.1%) for stenosis. The average length of clinical follow-up was 13.5 months. In terms of surgical characteristics, 172 (44.0%) patients received a 1-level decompression, 122 (31.2%) a 2-level decompression, 74 (18.9%) a 3-level decompression, 20 (5.1%) a 4-level decompression, and 3 (0.8%) a 5-level decompression. A total of 275 (70.3%) patients underwent a 1-level fusion, 92 (23.5%) a 2-level fusion, and 24 (6.2%) a 3-level fusion. Demographic data and surgical characteristics between groups in the primary analysis can be located in Table 1.

Table 1.

Descriptive statistics of cohort by mental health diagnosis groups. Descriptive characteristics between groups are compared via Kruskal-Wallis H test, Pearson χ2 analysis, or Fisher exact test.


No Depression or Anxiety (n =323)
Depression or Anxiety (n = 37)
Depression and Anxiety (n = 31)
P Value
Age, mean (95% CI), y 63.0 (61.0, 64.0) 62.0 (58.0, 66.0) 61.0 (58.0, 64.0) .809
Sex, n (%) .057
 M 168 (52.0) 21 (56.8) 23 (74.2)
 F 155 (48.0) 16 (43.2) 8 (25.8)
Body mass index, kg/m2 (95% CI) 30.4 (29.8, 31.1) 30.6 (29.1, 32.1) 30.7 (28.7, 32.8) .962
Smoking status, n (%) .001a
 Never 228 (70.6) 20 (54.1) 16 (51.6)
 Current 22 (6.8) 1 (2.7) 7 (22.6)
 Former 73 (22.6) 16 (43.2) 8 (25.8)
Preoperative diagnosis, n (%) .723
 Spondylolisthesis 228 (70.6) 23 (62.2) 21 (67.8)
 Scoliosis 43 (13.3) 5 (13.5) 5 (16.1)
 Recurrent disc herniation 11 (3.4) 1 (2.7) 0 (0.0)
 Stenosis 41 (12.7) 8 (21.6) 5 (16.1)
No. of levels decompressed, n (%) .750
 1 140 (43.3) 21 (56.8) 11 (35.5)
 2 103 (31.9) 7 (18.9) 12 (38.7)
 3 61 (18.9) 7 (18.9) 6 (19.4)
 4 16 (5.0) 2 (5.4) 2 (6.4)
 5 3 (0.9) 0 (0.0) 0 (0.0)
No. of levels fused, n (%) .279
 1 224 (69.3) 31 (83.8) 20 (64.5)
 2 78 (24.1) 6 (16.2) 8 (25.8)
 3 21 (6.6) 0 (0.0) 3 (9.7)
Follow-up, mean (95% CI), mo 13.6 (13.0, 14.1) 13.4 (12.4, 14.4) 13.3 (11.6, 15.1) .953
Symptom duration, n (%) .338
 <3 mo 238 (73.7) 28 (75.7) 19 (61.3)
 3-6 mo 50 (15.5) 4 (10.8) 9 (29.0)
 >6 mo 35 (10.8) 5 (13.5) 3 (9.7)
a

Indicates statistical significance (P < .05).

Patient-Reported Outcome Measurements

All groups demonstrated significant improvement after surgery in every PROM domain (P < .05), except that patients in the DOA group did not improve in terms of MCS-12 scores (P =.225). When comparing baseline outcome scores between groups, the DAA group was found to exhibit worse disability than the NDA group in terms of MCS-12 (42.3 versus 50.7, P < .001) and ODI scores (49.5 versus 40.0, P = .001). This trend was also observed for postoperative measurements, with the DAA group exhibiting significantly greater disability than the NDA group in terms of MCS-12 (47.3 versus 54.4, P < .001) and ODI (32.2 versus 19.9, P =.001). Neither delta scores, nor RRs, nor % MCID were found to be significantly different between any of the groups. In spite of this finding, multiple linear regression analysis revealed that the having either depression or anxiety alone (DAA) group was a significant predictor of decreased improvement in MCS-12 (β coefficient: −4.016 [95% CI: −7.551, −0.480], P = .026) and ODI (β coefficient: 11.768 [95% CI: 4.677, 18.858], P =.001) scores over time compared to the NDA group. Outcome comparisons between groups for the primary analysis can be located in Table 2.

Table 2.

Patient-reported outcome measurement comparisons between mental health diagnosis groups.


No Depression or Anxiety (n = 323)
Depression or Anxiety (n = 37)
Depression and Anxiety (n = 31)
P Valuea
β coefficient (95% CI), P Valueb
Depression or Anxiety
Depression and Anxiety
PCS-12
 Pre, mean (95% CI) 31.3 (30.3, 32.3) 30.8 (27.8, 33.7) 28.6 (26.1, 31.1) .265 0.962 (−2.709, 4.634), .606 −3.058 (−6.945, 0.828), .123
 Post, mean (95% CI) 40.5 (39.3, 41.6) 40.7 (37.9, 43.5) 35.9 (32.4, 39.4) .070
 Δ, mean (95% CI) 9.2 (7.9, 10.6) 10.0 (6.6, 13.4) 7.7 (4.4, 11.0) .708
 RR, %c 12.7 13.6 10.5 .735
 % MCIDd 51.4 42.4 53.6 .592
P valuee <.001f <.001f <.001f ...
MCS-12
 Pre, mean (95% CI) 50.7 (49.5, 52.0) 47.1 (43.0, 51.1) 42.3 (38.0, 46.7) <.001f −2.420 (−5.709, 0.869), .149 −4.016 (−7.551, −0.480), .026f
 Post, mean (95% CI) 54.4 (53.4, 55.4) 49.8 (45.9, 53.7) 47.3 (42.9, 51.7) <.001f
 Δ, mean (95% CI) 3.5 (2.2, 4.7) 2.9 (−2.3, 8.0) 4.6 (0.5, 8.7) .823
 RR, %c 4.3 2.4 6.9 .701
 % MCIDd 27.1 27.3 32.1 .847
P valuee <.001f .225 .030f ...
ODI
 Pre, mean (95% CI) 40.0 (38.1, 41.9) 48.1 (42.4, 53.7) 49.5 (43.4, 55.7) .001f 6.844 (−0.153, 13.840), .055 11.768 (4.677, 18.858), .001f
 Post, mean (95% CI) 19.9 (17.9, 21.8) 25.1 (18.9, 31.4) 32.2 (25.5, 38.9) .001f
 Δ, mean (95% CI) −20.1 (−22.5, −17.7) −20.9 (−28.7, −13.1) −15.2 (−24.5, −6.0) .497
 RR, %c 37.1 38.9 24.3 .819
 % MCIDd 74.5 73.3 64.3 .078
P valuee <.001f <.001f .002f ...
VAS back
 Pre, mean (95% CI) 5.8 (5.4, 6.1) 6.0 (4.9, 7.2) 6.7 (5.8, 7.7) .272 −0.241 (−1.265, 0.783), .644 0.664 (−0.395, 1.722), .218
 Post, mean (95% CI) 2.9 (2.6, 3.2) 2.5 (1.7, 3.2) 3.6 (2.5, 4.8) .195
 Δ, mean (95% CI) −3.0 (−3.4, −2.6) −3.6 (−4.9, −2.4) −2.9 (−4.4, −1.4) .573
 RR, %c 38.6 43.7 39.5 .951
 % MCIDd 56.3 65.5 60.0 .609
P valuee <.001f <.001f <.001f ...
VAS leg
 Pre, mean (95% CI) 6.0 (5.6, 6.3) 6.8 (5.7, 7.8) 6.4 (5.2, 7.6) .364 −0.045 (−1.161, 1.071), .937 0.736 (−0.412, 1.883), .208
 Post, mean (95% CI) 2.4 (2.1, 2.7) 2.1 (1.3, 2.9) 3.1 (1.9, 4.3) .290
 Δ, mean (95% CI) −3.6 (−4.1, −3.2) −4.4 (−5.5, −3.2) −3.3 (−5.1, −1.5) .498
 RR, %c 53.4 60.0 45.0 .600
 % MCIDd 59.7 75.9 60.0 .237
P valuee <.001f <.001f .001f

Abbreviations: CI, confidence interval; Δ, delta; MCS-12, Short Form-12 mental component score; ODI, Oswestry Disability Index; PCS-12, Short Form-12 physical component score; % MCID, percentage of patients reaching MCID at 1-year follow-up; Post, postoperative; Pre, preoperative; PROM, Patient-reported outcome measurement; RR, recovery ratio; VAS-back, Visual Analogue Score for back pain; VAS-leg, Visual Analogue Score for leg pain.

a

1-way ANOVA (Bonferroni post-hoc analysis), Kruskal-Wallis H test (Dunn multiple pairwise comparison post-hoc analysis), or Pearson χ2 analysis.

b

Multiple linear regression analysis.

c

Calculated for PROM improvement scores using this formula: (PROM Δ/[ideal score − preoperative PROM]). Ideal scores: PCS-12 and MCS-12 = 100; ODI, VAS back, and VAS leg = 0.

d

MCID cut-off values: PCS-12: 8.8, MCS-12: 9.3, ODI: 6.8, VAS Back: 2.1, and VAS Leg: 2.4.

e

Paired samples t test.

f

Indicates statistical significance (P < .05).

When conducting a secondary analysis by separating patients with depression alone (DO) or anxiety alone (AO), all groups again demonstrated significant improvement from baseline to postoperative measurements in all outcome measures except for the DO and AO groups—both of which failed to improve in terms of MCS-12 (P = .132 and P = .877, respectively). Comparing outcome scores between groups, the DAA still showed worse MCS-12 and ODI scores compared to the NDA group at baseline and postoperatively (P < .05). Neither delta scores, nor RRs, nor % MCID were found to be significantly different between groups. Multiple linear regression analysis again revealed that the DAA group was a significant predictor decreased improvement in MCS-12 (β coefficient: −3.988 [95% CI: −7.527, −0.450], P = .027) and ODI (β coefficient: 11.767 [95% CI: 4.665, 18.869], P = .001) scores over time, when using the NDA group as a baseline for comparison. Results of the secondary analysis are detailed in Table 3.

Table 3.

Patient-reported outcome measurement comparisons between mental health diagnosis groups (secondary analysis).

β Coefficient (95% CI), P Valueb

No Depression or Anxiety (n = 323)
Depression Alone (n = 24)
Anxiety Alone (n = 13)
Depression and Anxiety (n = 31)
P Valuea
No Depression or Anxiety
Depression Alone
Anxiety Alone
Depression and Anxiety
PCS-12
 Pre, mean (95% CI) 31.3 (30.3, 32.3) 29.5 (26.4, 32.5) 33.4 (26.3, 40.6) 28.6 (26.1, 31.1) .489 ... 1.089 (−3.362, 5.540), .631 0.720 (−5.321, 6.761), .815 −3.056 (−6.949, 0.836), .123
 Post, mean (95% CI) 40.5 (39.3, 41.6) 40.2 (36.1, 44.2) 41.6 (38.0, 45.2) 35.9 (32.4, 39.4) .113
 Δ, mean (95% CI) 9.2 (7.9, 10.6) 10.7 (6.1, 15.2) 8.6 (3.2, 14.1) 7.7 (4.4, 11.0) .830
 RRc 12.7% 14.6% 11.7% 10.5% .794
 % MCIDd 51.4% 45.5% 36.4% 53.6% .731
P valuee <.001f <.001f .006f <.001f
MCS-12
 Pre, mean (95% CI) 50.7 (49.5, 52.0) 45.6 (40.3, 50.8) 50.1 (42.9, 57.2) 42.3 (38.0, 46.7) .001f ... −1.590 (−5.581, 2.400), .434 −3.985 (−9.365, 1.394), .146 −3.988 (−7.527, −0.450), .027f
 Post, mean (95% CI) 54.4 (53.4, 55.4) 49.3 (44.5, 54.0) 50.7 (43.0, 58.4) 47.3 (42.9, 51.7) .001f
 Δ, mean (95% CI) 3.5 (2.3, 4.7) 4.6 (−2.1, 11.3) −0.6 (−9.6, 8.3) 4.6 (0.5, 8.7) .814
 RRc 4.3% 5.1% 2.1% 6.9% .821
 % MCIDd 27.1% 31.8% 18.2% 32.1% .797
P valuee <.001f .132 .877 .030f
ODI
 Pre, mean (95% CI) 40.0 (38.1, 41.9) 49.7 (42.7, 56.7) 44.6 (33.7, 55.5) 49.5 (43.4, 55.7) .002f ... 6.819 (−1.749, 15.387), .118 6.888 (−4.426, 18.202), .232 11.767 (4.665, 18.869), .001f
 Post, mean (95% CI) 19.9 (17.9, 21.8) 26.5 (18.1, 34.8) 22.7 (12.4, 33.1) 32.2 (25.5, 38.9) .001f
 Δ, mean (95% CI) −20.1 (−22.5, −17.7) −22.7 (−32.0, −13.3) −17.4 (−34.2, −0.6) −15.2 (−24.5, −6.0) .453
 RRc 37.1% 44.3% 28.1% 24.3% .027f
 % MCIDd 74.5% 75.0% 70.0% 51.9% .092
P valuee <.001f <.001f .044f .002f
VAS Back
 Pre, mean (95% CI) 5.8 (5.4, 6.1) 6.3 (4.9, 7.7) 5.4 (3.1, 7.7) 6.7 (5.8, 7.7) .431 ... −0.136 (−1.372, 1.099), .828 −0.452 (−2.185, 1.281), .608 0.667 (−0.394, 1.727), .217
 Post, mean (95% CI) 2.9 (2.6, 3.2) 2.8 (1.7, 3.9) 1.8 (0.8, 2.8) 3.6 (2.5, 4.8) .299
 Δ, mean (95% CI) −3.0 (−3.4, −2.6) −3.8 (−5.4, −2.3) −3.3 (−5.9, −0.6) −2.9 (−4.4, −1.4) .634
 RRc 38.6% 50.0% 29.7% 39.5% .839
 % MCIDd 56.3% 70.0% 55.6% 60.0% .677
P valuee <.001f <.001f .022f <.001f
VAS Leg
 Pre, mean (95% CI) 6.0 (5.6, 6.3) 7.5 (6.5, 8.5) 5.0 (2.4, 7.7) 6.4 (5.2, 7.6) .113 ... 0.162 (−1.192, 1.516), .814 −0.458 (−2.347, 1.430), .634 0.740 (−0.409, 1.889), .206
 Post, mean (95% CI) 2.4 (2.1, 2.7) 2.5 (1.4, 3.7) 1.4 (0.5, 2.2) 3.1 (1.9, 4.3) .490
 Δ, mean (95% CI) −3.6 (−4.1, −3.2) −4.9 (−6.2, −3.6) −3.3 (−6.0, −0.6) −3.3 (−5.1, −1.5) .501
 RRc 53.4% 61.8% 56.0% 45.0% .789
 % MCIDd 59.8% 80.0% 66.7% 60.0% .342
P valuee <.001f <.001f .021f .001f

Abbreviations: CI, confidence interval; Δ, delta; MCS-12, Short Form-12 mental component score; ODI, Oswestry Disability Index; PCS-12, Short Form-12 physical component score; % MCID, percentage of patients reaching MCID at 1-year follow-up; Post, postoperative; Pre, preoperative; PROM, Patient-reported outcome measurement; RR, recovery ratio; VAS-back, Visual Analogue Score for back pain; VAS-leg, Visual Analogue Score for leg pain.

a

1-way ANOVA (Bonferroni post-hoc analysis), Kruskal-Wallis H test (Dunn multiple pairwise comparison post-hoc analysis), or Pearson χ2 analysis.

b

Multiple linear regression analysis.

c

Calculated for PROM improvement scores using this formula: (PROM Δ/[ideal score − preoperative PROM]). Ideal scores: PCS-12 and MCS-12 = 100; ODI, VAS back, and VAS leg = 0.

d

MCID cut-off values: PCS-12: 8.8, MCS-12: 9.3, ODI: 6.8, VAS Back: 2.1, and VAS Leg: 2.4.

e

Paired samples t test.

f

Indicates statistical significance (P < .05).

DISCUSSION

The purpose of this study was to determine if, and to what extent, having preoperative depression and/or anxiety influences PROMs in patients who require lumbar fusion surgery to address degenerative lumbar disease. The results of the current study found that patients with combined depression and anxiety prior to lumbar fusion had worse pain and disability than patients who no prior mental health comorbidities in terms of MCS-12 and ODI scores (P < .001) both preoperatively and postoperatively. While the groups did not demonstrate any significant differences in the various measures of improvement including delta scores, recovery ratios, and % MCID for any PROMs in the analysis, multiple linear regression analyses indicated that having both combined depression and anxiety prior to surgery was a significant predictor of worse improvement in MCS-12 (P = .027) and ODI (P = .001), compared to having no baseline mental health diagnoses. These trends were also found in the secondary analysis.

Interestingly, patients having a single mental health diagnosis (DO or AO groups) did not improve with respect to MCS-12 scores, whereas patients with both (DAA) did improve. However, this may be related to the fact that MCS-12 represents the global mental functioning of a patient. Hence, patients with more baseline mental health dysfunction are likely to continue to experience this dysfunction after surgery. MCS-12 scores are closely related to the presence of depression and a few studies have attempted to define thresholds.2224

Current literature shows examining the impact of preoperative mental health and outcomes following lumbar arthrodesis shows conflicting reports. Several studies have associated anxiety and/or depression with less satisfaction and improvement, and worse health-related quality of life scores, after lumbar fusion when compared to patients with no preoperative mental health comorbidities. However, there are others that report opposite or neutral findings in this particular domain.1118 In one retrospective comparative study in patients that underwent instrumented lumbar decompression and fusion surgery for recurrent stenosis, patients with depression—identified by preoperative Zung self-rating depression score—were found to have significantly greater dissatisfaction scores 2 years after surgery (odds ratio = 0.67 [95% CI: 0.38, 0.87], P < .001).10 In a separate study, 231 patients who underwent lumbar fusion for any reason were retrospectively reviewed. The authors of this study found that a worse baseline EuroQOL-5 Dimensions score or a clinical diagnosis of depression, determined by the Patient Health Questionnaire-9, was associated with a significantly greater chance of not achieving MCID at 1 year of clinical follow-up (P < .05).11 Similarly, in a retrospective study by Wahlman et al16 examining 232 patients who underwent lumbar fusion, patients with preoperative symptoms of depression—identified by the Depression Scale—were found to have significantly less disability in terms of ODI at the 3-month and 1-year clinical follow-up visits (P < .001). The findings of these studies suggest that having preexisting depression seems to lead to worse outcomes even when using a variety of different measures. One plausible explanation between depression and outcomes is that they are inextricably linked because of the presence of chronic pain.2528

While the aforementioned studies have focused on depression alone as an independent risk factor for worse outcomes after lumbar fusion surgery, other studies have considered the influence of anxiety on outcomes. In a retrospective study by Lee et al,15 patients with depression or anxiety were identified using Hospital Anxiety and Depression Scale (HADS), noting that depression and anxiety were each significantly correlated with worse disability in terms of ODI scores (r = −0.054 and r = −0.276, respectively, P < .001) but not VAS scores. In another study by Carreon et al,28 patients' subjective feeling of being downhearted or depressed was a significant predictor of worse ODI scores after lumbar fusion. However, the same study indicated that a preoperative diagnosis of depression or anxiety did not significantly predict worse outcomes after arthrodesis. Finally, a prospective trial by Netto et al17 revealed that patients with depression or anxiety, identified by the HADS scale, were found to have significantly greater pain scores (P < .001), but the same level of physical functioning and improvement in ODI scores. The different results in the abovementioned studies may be attributed to unstandardized methods as well as instruments used. The results of the present study indicate that depression or anxiety alone were not associated with worse PROM improvement after lumbar fusion; however, combined depression and anxiety was associated with greater disability in terms of ODI scores. There are no other studies to date which have examined the impact that combined depression and anxiety have on patient-reported outcomes following lumbar fusion. This suggests that it may be important to consider anxiety in combination with depression when assessing the influence of mental health on PROMs.

There are several limitations to the current study including the fact the patients who were identified as having anxiety or depression through the medical chart were not verified by a validated outcome scale (ie HADS), but rather were rather listed as officially having one of these diagnoses at any point prior to surgery. This may have resulted in classifying patients who had a remote a history of major depressive disorder or generalized anxiety disorder who may have already received adequate treatment prior to surgery; hence, their preoperative mental health diagnosis may not be as accurate as originally anticipated. Furthermore, this would imply that patients with the mental health conditions who have never been formally diagnosed could also have been classified as having no depression and/or anxiety in spite of potentially subclinical baseline mental health symptoms. Incorrect classification of groups may have also resulted in the imbalanced sample sizes used for primary comparison (DOA: n = 37; DAA: n = 31), potentially weakening the findings of this study. Finally, the severity of the diagnoses was not determined, which would have helped further elucidate the impact of increasingly severe composite mental health states on PROMs after lumbar arthrodesis. With all of this in mind, the major limitations ascribed above are all related by the retrospective nature of the study, as certain details would have been better determined with appropriate prospective planning. Any studies that plan to further elucidate the relationship between mental health and PROMs after lumbar fusion should attempt to do so in a prospective manner; ultimately, this would result in more accurate baseline mental health diagnoses and thorough stratification of symptom severity at preoperative evaluations.

CONCLUSION

Patients with combined depression and anxiety were found to have significantly worse baseline and postoperative ODI scores compared to the subset of patients with no mental health comorbidities prior to surgery. Furthermore, having combined depression and anxiety was predictive of less improvement in terms of ODI scores. This is the first study to incorporate combined depression and anxiety as a risk factor for worse outcomes after lumbar fusion. More studies must be conducted to further elucidate this association.

Footnotes

Disclosures and COI: The authors, their immediate families, and any research foundation with which they are affiliated did not receive any financial payments or other benefits from any commercial entity related to the subject of this article. There are no relevant disclosures.

REFERENCES

  • 1.Martin BI, Mirza SK, Spina N, Spiker WR, Lawrence B, Brodke DS. Trends in lumbar fusion procedure rates and associated hospital costs for degenerative spinal diseases in the United States, 2004 to 2015. Spine. 2019;44(5):369–376. doi: 10.1097/BRS.0000000000002822. [DOI] [PubMed] [Google Scholar]
  • 2.Veresciagina K, Mehrkens A, Schären S, Jeanneret B. Minimum ten-year follow-up of spinal stenosis with degenerative spondylolisthesis treated with decompression and dynamic stabilization. J Spine Surg. 2018;4(1):93–101. doi: 10.21037/jss.2018.03.20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Schaeren S, Broger I, Jeanneret B. Minimum four-year follow-up of spinal stenosis with degenerative spondylolisthesis treated with decompression and dynamic stabilization. Spine. 2008;33(18):E636–642. doi: 10.1097/BRS.0b013e31817d2435. [DOI] [PubMed] [Google Scholar]
  • 4.Weinstein JN, Lurie JD, Tosteson TD, et al. Surgical versus nonsurgical treatment for lumbar degenerative spondylolisthesis. N Engl J Med. 2007;356(22):2257–2270. doi: 10.1056/NEJMoa070302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Weinstein JN, Lurie JD, Tosteson TD, et al. Surgical compared with nonoperative treatment for lumbar degenerative spondylolisthesis. Four-year results in the Spine Patient Outcomes Research Trial (SPORT) randomized and observational cohorts. J Bone Joint Surg Am. 2009;91(6):1295–1304. doi: 10.2106/JBJS.H.00913. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Sun W, Xue C, Tang X-Y, et al. Selective versus multi-segmental decompression and fusion for multi-segment lumbar spinal stenosis with single-segment degenerative spondylolisthesis. J Orthop Surg. 2019;14(1):46. doi: 10.1186/s13018-019-1092-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.O'Connell C, Azad TD, Mittal V, et al. Preoperative depression, lumbar fusion, and opioid use: an assessment of postoperative prescription, quality, and economic outcomes. Neurosurg Focus. 2018;44(1):E5. doi: 10.3171/2017.10.FOCUS17563. [DOI] [PubMed] [Google Scholar]
  • 8.Derby R, Lettice JJ, Kula TA, Lee S-H, Seo K-S, Kim B-J. Single-level lumbar fusion in chronic discogenic low-back pain: psychological and emotional status as a predictor of outcome measured using the 36-item Short Form. J Neurosurg Spine. 2005;3(4):255–261. doi: 10.3171/spi.2005.3.4.0255. [DOI] [PubMed] [Google Scholar]
  • 9.Schoell K, Wang C, D'Oro A, et al. Depression increases the rates of neurological complications and failed back surgery syndrome in patients undergoing lumbar spine surgery. Clin Spine Surg. 2019;32(2):E78. doi: 10.1097/BSD.0000000000000730. [DOI] [PubMed] [Google Scholar]
  • 10.Adogwa O, Carr K, Fatemi P, et al. Psychosocial factors and surgical outcomes: are elderly depressed patients less satisfied with surgery. Spine. 2014;39(19):1614–1619. doi: 10.1097/BRS.0000000000000474. [DOI] [PubMed] [Google Scholar]
  • 11.Alentado VJ, Caldwell S, Gould HP, Steinmetz MP, Benzel EC, Mroz TE. Independent predictors of a clinically significant improvement after lumbar fusion surgery. Spine J. 2017;17(2):236–243. doi: 10.1016/j.spinee.2016.09.011. [DOI] [PubMed] [Google Scholar]
  • 12.Miller JA, Derakhshan A, Lubelski D, et al. The impact of preoperative depression on quality of life outcomes after lumbar surgery. Spine J. 2015;15(1):58–64. doi: 10.1016/j.spinee.2014.06.020. [DOI] [PubMed] [Google Scholar]
  • 13.Merrill RK, Zebala LP, Peters C, Qureshi SA, McAnany SJ. Impact of depression on patient-reported outcome measures after lumbar spine decompression. Spine. 2018;43(6):434–439. doi: 10.1097/BRS.0000000000002329. [DOI] [PubMed] [Google Scholar]
  • 14.Høy K, Bünger C, Niederman B, et al. Transforaminal lumbar interbody fusion (TLIF) versus posterolateral instrumented fusion (PLF) in degenerative lumbar disorders: a randomized clinical trial with 2-year follow-up. Eur Spine J. 2013;22(9):2022–2029. doi: 10.1007/s00586-013-2760-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Lee J, Kim H-S, Shim K-D, Park Y-S. The effect of anxiety, depression, and optimism on postoperative satisfaction and clinical outcomes in lumbar spinal stenosis and degenerative spondylolisthesis patients: cohort study. Clin Orthop Surg. 2017;9(2):177–183. doi: 10.4055/cios.2017.9.2.177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Wahlman M, Häkkinen A, Dekker J, Marttinen I, Vihtonen K, Neva MH. The prevalence of depressive symptoms before and after surgery and its association with disability in patients undergoing lumbar spinal fusion. Eur Spine J. 2014;23(1):129–134. doi: 10.1007/s00586-013-2896-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Netto MB, Barranco ABS, Oliveira KWK de, Petronilho F. Influence of anxiety and depression symptoms on the quality of life in patients undergoing lumbar spine surgery. Rev Bras Ortop. 2017;53(1):38–44. doi: 10.1016/j.rboe.2017.01.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Abbott AD, Tyni-Lenné R, Hedlund R. The influence of psychological factors on pre-operative levels of pain intensity, disability and health-related quality of life in lumbar spinal fusion surgery patients. Physiotherapy. 2010;96(3):213–221. doi: 10.1016/j.physio.2009.11.013. [DOI] [PubMed] [Google Scholar]
  • 19.Radcliff K, Davis RJ, Hisey MS, et al. Long-term evaluation of cervical disc arthroplasty with the Mobi-C© cervical disc: a randomized, prospective, multicenter clinical trial with seven-year follow-up. Int J Spine Surg. 2017;11:31. doi: 10.14444/4031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Parker SL, Mendenhall SK, Shau DN, et al. Minimum clinically important difference in pain, disability, and quality of life after neural decompression and fusion for same-level recurrent lumbar stenosis: understanding clinical versus statistical significance. J Neurosurg Spine. 2012;16(5):471–478. doi: 10.3171/2012.1.SPINE11842. [DOI] [PubMed] [Google Scholar]
  • 21.Parker SL, Adogwa O, Paul AR, et al. Utility of minimum clinically important difference in assessing pain, disability, and health state after transforaminal lumbar interbody fusion for degenerative lumbar spondylolisthesis. J Neurosurg Spine. 2011;14(5):598–604. doi: 10.3171/2010.12.SPINE10472. [DOI] [PubMed] [Google Scholar]
  • 22.Gill SC, Butterworth P, Rodgers B, Mackinnon A. Validity of the mental health component scale of the 12-item Short-Form Health Survey (MCS-12) as measure of common mental disorders in the general population. Psychiatry Res. 2007;152(1):63–71. doi: 10.1016/j.psychres.2006.11.005. [DOI] [PubMed] [Google Scholar]
  • 23.Walsh TL, Homa K, Hanscom B, Lurie J, Sepulveda MG, Abdu W. Screening for depressive symptoms in patients with chronic spinal pain using the SF-36 health survey. Spine J. 2006;6(3):316–320. doi: 10.1016/j.spinee.2005.11.004. [DOI] [PubMed] [Google Scholar]
  • 24.Gornet MF, Copay AG, Schranck FW, Kopjar B. observational study of depression in patients undergoing cervical disc arthroplasty: evidence of a correlation between pain relief and resolution of depression. Int J Spine Surg. 2016;10:11. doi: 10.14444/3011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Bair MJ, Wu J, Damush TM, Sutherland JM, Kroenke K. Association of depression and anxiety alone and in combination with chronic musculoskeletal pain in primary care patients. Psychosom Med. 2008;70(8):890–897. doi: 10.1097/PSY.0b013e318185c510. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.McWilliams LA, Cox BJ, Enns MW. Mood and anxiety disorders associated with chronic pain: an examination in a nationally representative sample. Pain. 2003;106(1–2):127–133. doi: 10.1016/s0304-3959(03)00301-4. [DOI] [PubMed] [Google Scholar]
  • 27.Scott KM, Bruffaerts R, Tsang A, et al. Depression-anxiety relationships with chronic physical conditions: results from the World Mental Health Surveys. J Affect Disord. 2007;103(1–3):113–120. doi: 10.1016/j.jad.2007.01.015. [DOI] [PubMed] [Google Scholar]
  • 28.Carreon LY, Djurasovic M, Dimar JR, et al. Can the anxiety domain of EQ-5D and mental health items from SF-36 help predict outcomes after surgery for lumbar degenerative disorders. J Neurosurg Spine. 2016;25(3):352–356. doi: 10.3171/2016.2.SPINE151472. [DOI] [PubMed] [Google Scholar]

Articles from International Journal of Spine Surgery are provided here courtesy of International Society for the Advancement of Spine Surgery

RESOURCES